661 - 670 of 6570 Results
Title
Year
-
OPENTitle: Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson’s diseaseJournal Name: PLOS Digital HealthPublisher: Public Library of Science (PLoS)Vol: 2Issue #: 4Start Page: e0000225End Page: e0000225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pdig.0000225Best OA location URL: https://journals.plos.org/digitalhealth/article/file?id=10.1371/journal.pdig.0000225&type=printableCitation Count: 7
-
OPENTitle: Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 55End Page: 55Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00502-3Best OA location URL: https://www.nature.com/articles/s41531-023-00502-3.pdfCitation Count: 15
-
OPENTitle: Parkinson’s disease population-wide registries in the United States: Current and future opportunitiesJournal Name: Frontiers in Digital HealthPublisher: Frontiers Media SAVol: 5Issue #:Start Page: 1149154End Page: 1149154Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdgth.2023.1149154Best OA location URL: https://www.frontiersin.org/articles/10.3389/fdgth.2023.1149154/pdfCitation Count: 9
-
OPENTitle: Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activitiesJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 184Issue #:Start Page: 106409End Page: 106409Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2022.106409Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10074477/pdf/nihms-1882815.pdfCitation Count: 16
-
OPENTitle: In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson’s disease using neuromelanin-sensitive MRI: Replication in two cohortsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 4Start Page: e0282684End Page: e0282684Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0282684Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0282684&type=printableCitation Count: 22
-
OPENTitle: Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and OlderJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 16Start Page: e1691End Page: e1701Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1212/wnl.0000000000207077Best OA location URL: https://n.neurology.org/content/neurology/early/2023/02/27/WNL.0000000000207077.full.pdfCitation Count: 68
-
OPENTitle: Decreased Water Mobility Contributes To Increased α‐Synuclein Aggregation**Journal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 7Start Page: e202212063End Page: e202212063Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/anie.202212063Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202212063Citation Count: 26
-
OPENTitle: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European AmericansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 572End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12435Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8789942Citation Count: 34
-
OPENTitle: Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2022Issue #: 1Start Page: 5597503End Page: 5597503Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/5597503Best OA location URL: https://downloads.hindawi.com/journals/pd/2022/5597503.pdfCitation Count: 5
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page: e376End Page: e389Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 133